560130-42-9CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.ClGSSIWSIRBWAZHG-ACOPVEIWSA-NTelavancin hydrochloride is a hydrochloride obtained by combining telavancin and hydrochloric acid. The composition of the compound is telavancin.nHCl where n = 1-3. Used for treatment of adults with complicated skin and skin structure infections caused by bacteria. It has a role as an antimicrobial agent and an antibacterial drug. It contains a telavancin.
Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Glycopeptides; Lipoglycopeptides
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
TELAVANCIN HYDROCHLORIDE
Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [EXT]
VerwendenAntibacterial agent active against gram-positive pathogens.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
560130-42-9CHEMBL3301680CHEBI:71226DefinitionChEBI: A hydrochloride obtained by combining telavancin and hydrochloric acid. The composition of the compound is telavancin.nHCl where n = 1-3. Used for treatment of adults with complicated skin and skin structure infections caused by bacteria.